Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Luc De Clerck"'
Autor:
Piet Geusens, Laurent Meric de Bellefon, Patrick Durez, Ruth Wittoek, Luc De Clerck, Jan Lenaerts, René Westhovens, Kurt de Vlam, Marie Vanthuyne, Yves Piette, Isabelle Peene, Anne Durnez, Bert Vander Cruyssen, Sofia Ajeganova, Pauline Montigny, Sofia Pazmino, Johan Joly, Patrick Verschueren, Rik Joos, Christian von Frenckell, Clio Ribbens, Béatrice André, Michel Malaise, Delphine Bertrand, Luk Corluy, Veerle Taelman, Isabelle Ravelingien, Elke Geens, Johan Vanhoof, Els Van Essche, Barbara Neerinckx, Ioana Gofita, Elisa Docampo, Muriel Stubbe, Mieke Devinck, Bea Maeyaert, YVES BOUTSEN, Mihaela Maruseac, Michael Doumen, Alla Ishchenko, Stephanie Dierckx, Mark Walschot, Marie-Joëlle Kaiser, Philip Remans, Kristof Thevissen, Tom Zwaenepoel, Silvana Di Romana, Marc Vanden Berghe, Joëlle Margaux, Jan Van Offel, Elias De Meyst, Myroslava Kulyk, Nelly Creten, Anna Sileghem, Hubert Berghs, Marleen Coppens, Pascale Volders, Christine Langenaeken, Femke Meynen, Isabelle de Wergifosse, Caroline Verbist, Spyridon Kefalas, Celine Brasseur, Mihaela Sarbu, Charline Rinkin, Sandrine Halleux, Maria Jose Fernandez, Marijke Van Hoydonck, Bernard Bouchez, Catherine Naveau, Emmanuelle Caussin, Jean-Pol Dufour, Véronique Pauly, Kathleen Declerck, Stijn Michiels, Joke Vanderstukken, Evelien Deboeck, Anneleen Moeyersoons, Louis Van Praet, Gilles Blondiaux, Jean-Pierre Brasseur, Laure Tant, Muhammad Soyfoo
Publikováno v:
RMD Open, Vol 10, Iss 3 (2024)
Objectives To investigate if patients with early rheumatoid arthritis responding insufficiently to initial methotrexate (MTX) and bridging glucocorticoids (GCs) could benefit from early but temporary etanercept introduction as a second remission-indu
Externí odkaz:
https://doaj.org/article/cd8d4c0fe99449019149159bcb1998a7
Autor:
Luisa Vonghia, Nathalie Ruyssers, Dorien Schrijvers, Paul Pelckmans, Peter Michielsen, Luc De Clerck, Albert Ramon, Emilio Jirillo, Didier Ebo, Benedicte De Winter, Chris Bridts, Sven Francque
Publikováno v:
Mediators of Inflammation, Vol 2015 (2015)
Background and Aims. Inflammatory mediators that cross-talk in different metabolically active organs are thought to play a crucial role in the pathogenesis of Nonalcoholic Steatohepatitis (NASH). This study was aimed at investigating the CD4+RORγt+
Externí odkaz:
https://doaj.org/article/9cc4ceb014cf483f89e64ccd2c5e4318
Autor:
Herman Mielants, Patrick Durez, Stijn Van Looy, Rene Westhovens, Nathan Vastesaeger, Luc De Clerck, Filip Van den Bosch, Luc Boullart, Leon Verbruggen, Filip De Keyser, A. Geldhof, Bert Vander Cruyssen, Ann Peretz, Bart Wyns, Michel Malaise
Publikováno v:
Arthritis Research & Therapy. 8:R112
Although there is strong evidence supporting the short-term efficacy and safety of anti-tumour necrosis factor-α agents, few studies have examined the long-term effects. We evaluated 511 patients with long-standing refractory rheumatoid arthritis tr
Autor:
A. Geldhof, Rene Westhovens, Eric Veys, Luc De Clerck, Bart Wyns, Filip De Keyser, Bert Vander Cruyssen, Luc Boullart, Leon Verbruggen, Michel Malaise, A. Peretz, Herman Mielants, Stijn Van Looy, Patrick Durez, Nathan Vastesaeger, Filip Van den Bosch
Publikováno v:
Arthritis Research & Therapy. 7:R1063
This study is based on an expanded access program in which 511 patients suffering from active refractory rheumatoid arthritis (RA) were treated with intravenous infusions of infliximab (3 mg/kg+methotrexate (MTX)) at weeks 0, 2, 6 and every 8 weeks t
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.